In January 2022 marketing authorization was received in Moldova for Airing™. Airing™ has been licensed from Mithra (Belgium) and is a generic version of Nuvaring™, a hormonal contraceptive vaginal ring. Market introduction is expected for the second half of 2023.
Marketing authorization in Ukraine is expected for the second half of 2023.
Airing™ (etonogestrel/ethinyl estradiol vaginal ring) is a non-biodegradable, flexible, transparent, combination contraceptive vaginal ring, with an outer diameter of 54 mm and a cross-sectional diameter of 4 mm. It is made of ethylene vinylacetate copolymers, and contains 11.7 mg etonogestrel and 2.7 mg ethinyl estradiol. When placed in the vagina, each ring releases, in line with the originator (Nuvaring®), on average 0.120 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol over a three-week period of use. The ring is to remain in place continuously for three weeks. It is removed for a one-week break, during which a withdrawal bleed usually occurs. A new ring is inserted one week after the last ring was removed.